Erratum: Repaglinide vs. Nateglinide Metformin Combination Study Group: Efficacy and safety of combination therapy: Repaglinide plus metformin versus nateglinide plus metformin (Diabetes Care (2003) 26 (2063-2068))

P. Raskin, L. Klaff, J. McGill, S. A. South, P. Hollander, N. Khutoryansky, P. M. Hale

Research output: Contribution to journalComment/debate

Original languageEnglish
Pages (from-to)2708
Number of pages1
JournalDiabetes care
Issue number9
StatePublished - Sep 1 2003

Cite this